AR109907A2 - Métodos para la producción de proteínas morfogenéticas óseas - Google Patents
Métodos para la producción de proteínas morfogenéticas óseasInfo
- Publication number
- AR109907A2 AR109907A2 ARP170102812A ARP170102812A AR109907A2 AR 109907 A2 AR109907 A2 AR 109907A2 AR P170102812 A ARP170102812 A AR P170102812A AR P170102812 A ARP170102812 A AR P170102812A AR 109907 A2 AR109907 A2 AR 109907A2
- Authority
- AR
- Argentina
- Prior art keywords
- production
- bmp
- methods
- concentration
- present
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/51—Bone morphogenetic factor; Osteogenins; Osteogenic factor; Bone-inducing factor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/38—Chemical stimulation of growth or activity by addition of chemical compounds which are not essential growth factors; Stimulation of growth by removal of a chemical compound
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/0018—Culture media for cell or tissue culture
- C12N5/0037—Serum-free medium, which may still contain naturally-sourced components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0681—Cells of the genital tract; Non-germinal cells from gonads
- C12N5/0682—Cells of the female genital tract, e.g. endometrium; Non-germinal cells from ovaries, e.g. ovarian follicle cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/05—Inorganic components
- C12N2500/10—Metals; Metal chelators
- C12N2500/20—Transition metals
- C12N2500/24—Iron; Fe chelators; Transferrin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/90—Polysaccharides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2510/00—Genetically modified cells
- C12N2510/02—Cells for production
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Tropical Medicine & Parasitology (AREA)
- Gastroenterology & Hepatology (AREA)
- Physical Education & Sports Medicine (AREA)
- Virology (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Rheumatology (AREA)
- Reproductive Health (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
Se proporcionan métodos y procesos para la producción de proteína recombinante. Los métodos son útiles para la producción de factores de crecimiento, en particular los de la superfamilia de TGF-b, que incluyen. proteínas morfogenéticas óseas (BMP), tales como BMP-2. Las células huésped adecuadas se cultivan en un medio en donde el hierro está presente en una concentración de al menos 2,25 mM y si el piridoxal está presente, constituye menos de 55% de la concentración molar de vitamina B6 del medio. Reivindicación 1: Un método de producción de BMP-2 que comprende las etapas de: i) cultivar una célula huésped adecuada que comprende una molécula de ADN que codifica una BMP-2 en un medio de cultivo que comprende hierro en una concentración de al menos 2,25 mM, un compuesto polianiónico y si está presente piridoxal, constituye menos de 55% de la concentración molar de vitamina B6 en el medio de cultivo; y ii) recuperar la proteína de interés, en donde la célula huésped se cultiva en un biorreactor que tiene una capacidad mayor de 3 L.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4564308P | 2008-04-17 | 2008-04-17 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR109907A2 true AR109907A2 (es) | 2019-02-06 |
Family
ID=40740265
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090101366 AR071484A1 (es) | 2008-04-17 | 2009-04-17 | Metodos para la produccion aumentada de proteinas morfogeneticas oseas, tales como bmp-2. |
| ARP170102812A AR109907A2 (es) | 2008-04-17 | 2017-10-09 | Métodos para la producción de proteínas morfogenéticas óseas |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP090101366 AR071484A1 (es) | 2008-04-17 | 2009-04-17 | Metodos para la produccion aumentada de proteinas morfogeneticas oseas, tales como bmp-2. |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US8039231B2 (es) |
| EP (1) | EP2310523B1 (es) |
| JP (2) | JP5739324B2 (es) |
| KR (1) | KR101286895B1 (es) |
| CN (2) | CN107090481A (es) |
| AR (2) | AR071484A1 (es) |
| AU (1) | AU2009236187B2 (es) |
| CA (1) | CA2720980C (es) |
| CL (1) | CL2009000912A1 (es) |
| DK (1) | DK2310523T3 (es) |
| ES (1) | ES2543061T3 (es) |
| HU (1) | HUE027035T2 (es) |
| IL (1) | IL208732A (es) |
| MX (1) | MX2010011356A (es) |
| PL (1) | PL2310523T3 (es) |
| PT (1) | PT2310523E (es) |
| SI (1) | SI2310523T1 (es) |
| WO (1) | WO2009129379A1 (es) |
| ZA (1) | ZA201007099B (es) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8039231B2 (en) * | 2008-04-17 | 2011-10-18 | Wyeth Llc | Methods for enhanced production of bone morphogenetic proteins |
| US11078248B2 (en) | 2010-03-19 | 2021-08-03 | Lifenet Health | BMP peptides and methods of use |
| WO2011116391A1 (en) * | 2010-03-19 | 2011-09-22 | Lifenet Health | Bmp-2 peptides & methods of use |
| WO2011119833A2 (en) * | 2010-03-24 | 2011-09-29 | Lifenet Health | Bmp-7 peptides & methods of use |
| EP2550006B1 (en) * | 2010-03-24 | 2018-08-22 | Lifenet Health | Bmp-4 peptides&methods of use |
| WO2012006594A1 (en) | 2010-07-08 | 2012-01-12 | Baxter International Inc. | Method of producing recombinant adamts13 in cell culture |
| US20130045471A1 (en) * | 2011-02-25 | 2013-02-21 | Bio-Rad Laboratories, Inc. | Training system for investigations of bioengineered proteins |
| TW201247874A (en) * | 2011-05-25 | 2012-12-01 | United Biomedical Inc | Method for producing the activity of bone activating protein |
| US20130281355A1 (en) * | 2012-04-24 | 2013-10-24 | Genentech, Inc. | Cell culture compositions and methods for polypeptide production |
| US10047141B2 (en) * | 2014-01-30 | 2018-08-14 | Coherus Biosciences, Inc. | Method of manufacturing a protein by perfusion in media with a low amino acid concentration |
| EP3612637A4 (en) | 2017-04-21 | 2021-01-27 | Yuhan Corporation | PROCESS FOR THE PRODUCTION OF DUAL FUNCTION PROTEINS AND THEIR DERIVATIVES |
| KR102056075B1 (ko) * | 2018-06-05 | 2020-01-22 | 한국과학기술원 | 목적 단백질의 생산을 향상시키기 위한 동물세포 배양용 배지 조성물 및 이를 이용한 목적 단백질 생산 방법 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5013649A (en) | 1986-07-01 | 1991-05-07 | Genetics Institute, Inc. | DNA sequences encoding osteoinductive products |
| US5318898A (en) | 1991-04-02 | 1994-06-07 | Genetics Institute, Inc. | Production of recombinant bone-inducing proteins |
| US5830761A (en) | 1995-06-07 | 1998-11-03 | Genetics Institute, Inc. | Medium and methods for culturing mammalian cho cells |
| US20030036629A1 (en) | 1997-12-12 | 2003-02-20 | Barry Foster | Novel tgf-beta protein purification methods |
| WO2002077006A1 (en) * | 2001-03-23 | 2002-10-03 | Human Genome Sciences, Inc. | Bone morphogenic protein polynucleotides, polypeptides, and antibodies |
| US20030087372A1 (en) | 2001-06-13 | 2003-05-08 | Genentech, Inc. | Methods of culturing animal cells and polypeptide production in animal cells |
| SI1623019T1 (sl) | 2003-05-15 | 2010-10-29 | Wyeth Llc | Omejeno glukozno dovajanje za živalsko celično kulturo |
| TWI374935B (en) * | 2004-08-27 | 2012-10-21 | Pfizer Ireland Pharmaceuticals | Production of α-abeta |
| TWI364458B (en) * | 2004-08-27 | 2012-05-21 | Wyeth Res Ireland Ltd | Production of tnfr-lg |
| US7294484B2 (en) * | 2004-08-27 | 2007-11-13 | Wyeth Research Ireland Limited | Production of polypeptides |
| PL1807504T3 (pl) * | 2004-11-02 | 2011-07-29 | Ares Trading Sa | Bezsurowicza pożywka hodowlana dla komórek ssaczych |
| US8039231B2 (en) * | 2008-04-17 | 2011-10-18 | Wyeth Llc | Methods for enhanced production of bone morphogenetic proteins |
-
2009
- 2009-04-16 US US12/425,056 patent/US8039231B2/en active Active
- 2009-04-16 CN CN201710073166.XA patent/CN107090481A/zh active Pending
- 2009-04-16 MX MX2010011356A patent/MX2010011356A/es active IP Right Grant
- 2009-04-16 DK DK09733052.6T patent/DK2310523T3/en active
- 2009-04-16 ES ES09733052.6T patent/ES2543061T3/es active Active
- 2009-04-16 KR KR1020107025696A patent/KR101286895B1/ko active Active
- 2009-04-16 SI SI200931216T patent/SI2310523T1/sl unknown
- 2009-04-16 PL PL09733052T patent/PL2310523T3/pl unknown
- 2009-04-16 WO PCT/US2009/040789 patent/WO2009129379A1/en not_active Ceased
- 2009-04-16 CA CA 2720980 patent/CA2720980C/en active Active
- 2009-04-16 CN CN2009801179302A patent/CN102037132A/zh active Pending
- 2009-04-16 AU AU2009236187A patent/AU2009236187B2/en active Active
- 2009-04-16 EP EP09733052.6A patent/EP2310523B1/en active Active
- 2009-04-16 JP JP2011505197A patent/JP5739324B2/ja active Active
- 2009-04-16 PT PT97330526T patent/PT2310523E/pt unknown
- 2009-04-16 HU HUE09733052A patent/HUE027035T2/hu unknown
- 2009-04-16 CL CL2009000912A patent/CL2009000912A1/es unknown
- 2009-04-17 AR ARP090101366 patent/AR071484A1/es not_active Application Discontinuation
-
2010
- 2010-10-05 ZA ZA2010/07099A patent/ZA201007099B/en unknown
- 2010-10-14 IL IL20873210A patent/IL208732A/en active IP Right Grant
-
2015
- 2015-01-20 JP JP2015008501A patent/JP2015109854A/ja active Pending
-
2017
- 2017-10-09 AR ARP170102812A patent/AR109907A2/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009236187B2 (en) | 2012-08-02 |
| EP2310523B1 (en) | 2015-06-10 |
| CA2720980A1 (en) | 2009-10-22 |
| PT2310523E (pt) | 2015-09-07 |
| CA2720980C (en) | 2014-02-25 |
| JP5739324B2 (ja) | 2015-06-24 |
| KR101286895B1 (ko) | 2013-07-16 |
| CN107090481A (zh) | 2017-08-25 |
| AR071484A1 (es) | 2010-06-23 |
| AU2009236187A1 (en) | 2009-10-22 |
| IL208732A (en) | 2014-07-31 |
| EP2310523A1 (en) | 2011-04-20 |
| US20090317867A1 (en) | 2009-12-24 |
| ES2543061T3 (es) | 2015-08-14 |
| DK2310523T3 (en) | 2015-07-20 |
| CL2009000912A1 (es) | 2009-10-09 |
| HUE027035T2 (hu) | 2016-08-29 |
| ZA201007099B (en) | 2011-06-29 |
| SI2310523T1 (sl) | 2015-10-30 |
| IL208732A0 (en) | 2010-12-30 |
| WO2009129379A1 (en) | 2009-10-22 |
| JP2011518175A (ja) | 2011-06-23 |
| US8039231B2 (en) | 2011-10-18 |
| PL2310523T3 (pl) | 2015-10-30 |
| KR20110005874A (ko) | 2011-01-19 |
| MX2010011356A (es) | 2010-11-09 |
| CN102037132A (zh) | 2011-04-27 |
| JP2015109854A (ja) | 2015-06-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR109907A2 (es) | Métodos para la producción de proteínas morfogenéticas óseas | |
| CO6241166A2 (es) | Metodos de produccion de proteinas utilizando compuestos anti-senectud | |
| EA200801074A1 (ru) | Способы получения искусственных гибридных семян | |
| ECSP088395A (es) | Método de producción proteica utilizando compuestos anti-senescencia | |
| MX2021000209A (es) | Metodos y productos para transfeccion de celulas. | |
| PL2144929T3 (pl) | Poprawa mian polipeptydu czynnika VIII w hodowlach komórkowych | |
| BR122019022434B8 (pt) | método para cultivar células de mamífero que secretam proteína heteróloga em um sobrenadante de cultura celular | |
| CY1119923T1 (el) | Μεθοδοι για αυξημενη παραγωγη πρωτεϊνων | |
| WO2011075686A3 (en) | Methods & compositions comprising heat shock proteins | |
| AR069253A1 (es) | Plantas transgenicas que expresan el acido nucleico de ossik1 y moduladores para aumentar la tolerancia a estres | |
| WO2011091350A3 (en) | Methods & compositions for improving protein production | |
| NZ595476A (en) | Plant snf1-related protein kinase gene | |
| UY31875A (es) | Novedosos genes involucrados en la biosíntesis | |
| BRPI0619579B8 (pt) | Métodos para aumentar a expectativa de vida replicativa e/ou estabilidade de uma célula produtora de anticorpo, para expressar um gene de uma célula b codificando a cadeia pesada de ig e/ou cadeia leve de ig, para produzir linhagem de células b, para obter anticorpos, e, método ex vivo para produzir anticorpos capazes de especificamente ligar um antígeno de interesse | |
| NO20072719L (no) | Serumfritt cellekulturmedium for pattedyrceller | |
| MX2012007117A (es) | Metodo para cultivar celulas adherentes. | |
| EA201070229A1 (ru) | Нуклеотидные последовательности msca1, влияющие на мужскую фертильность растений, и способ их применения | |
| WO2008024769A3 (en) | Intensified perfusion production method | |
| PH12012502520A1 (en) | Plants having enhanced yield-related traits and method for making the same | |
| DE602006016735D1 (de) | Verfahren zur proliferation von stammzellen | |
| AR043862A1 (es) | Procedimiento para la obtencion de estirpes celulares de mastocitos a partir de tejidos de cerdo y procedimiento para la produccion de moleculas de tipo de la heparina | |
| MX2022000002A (es) | Método para cultivo de células adherentes en un biorreactor multiparalelo. | |
| ATE479741T1 (de) | Zellkulturenmedium und verfahren zur kultivierung von stammzellen und vorläuferzellen | |
| JP2013500003A5 (es) | ||
| EP2067857A4 (en) | PROCESS FOR DIPEPTIDE PRODUCTION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC | Refusal |